Clinical Trial Update: Third-Generation Nanopore HPV Integration Site for Precise Prediction of Cervical Cancer Prognosis

View source ↗

Summary

Complete clinical trial update evaluating a third-generation Nanopore sequencing approach to detect HPV integration sites for predicting prognosis in cervical c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Cervical Cancers, HPV Testing | Status: COMPLETED